New Weight Loss Drugs: Overview and Implications, with Sara Stahl, Healthcare Director of Research, AlphaSense Expert Insights

Episode SummaryIn this episode of Signals, Nick Mazing welcomes Sara Stahl, Director of Research, Healthcare, at AlphaSense Expert Insights. They explore the new generation of weight loss drugs, a hot topic that's making waves everywhere.The conversation focuses on the efficacy of these drugs and the massive market potential they hold. Sara highlights the rising obesity epidemic and the potential these drugs have in combating it. She discusses the mechanism of action of the GLP-1 agonis...